Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > Publications > Research Monographs >    

Opioid Peptides: Molecular Pharmacology, Biosynthesis, and Analysis

NIDA Research Monograph, Number 70 [Printed in 1986]

Get Adobe Reader

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph70.pdf - Opioid Peptides: Molecular Pharmacology, Biosynthesis, and Analysis (4.6 MB)

Marvin Snyder

Rao S. Rapaka

Folding and Enzymatic Processing of Precursors of Biologically Active Peptides and Proteins-----3
Irwin M. Chaiken; Tatsuhiko Kanmera; and Reginald P. Sequeira

Biosynthesis of Opioid Peptides-----21
Olivier Civelli; Jim Douglass; Haim Rosen; Gerard Martens; and Edward Herbert

Proenkephalin Biosynthesis in the Rat-----43
Richard D. Howells

Enzymes in the Metabolism of Opioid Peptides: Isolation, Assay, and Specificity-----66
Neville Marks; Myron Benuck; and Martin J. Berg

Isolation and Identification of Opioid Peptides-----92
Hisayuki Matsuo

B-Endorphin: Naturally Occurring or Synthetic Agonists and Antagonists-----109
Choh Hao Li

Enkephalin Degrading Enzyme Inhibitors: A Physiological Way to New Analgesics and Psychoactive Agents-----128
Bernard P. Roques and Marie-Claude Fournie-Zaluski

Progress in the Characterization of the Opioid Receptor Subtypes: Peptides as Probes. Future Directions-----155
Eric J. Simon

Regulation of Agonist Binding to Opioid Receptor Types by Sodium and GTP: Relevance to Receptor Function-----175
Brian M. Cox; Linda L. Werling; and Gary Zarr

Opioid Receptors for the Dynorphin Peptides-----192
Iaian F. James

Computer Analysis of Radioligand Data: Advantages, Problems, and Pitfalls-----209
David Rodbard; Rudolph A. Lutz; Ricardo A. Cruciani; Vincenzo Guardabasso; Guido 0. Pesce; and Peter J. Munson

Recent Developments in Bioassay Using Selective Ligands and Selective In Vitro Preparations-----223
Hans W. Kosterlitz; Alistair D. Corbett; Maureen G. C. Gillan; Alexander T. McKnight; Stewart J. Paterson; and Linda E. Robson

Endorphins and Memory Regulation-----237
Ivan Izquierdo; Carlos A. Netto; and Renato D. Dias

Current Status of RIA Methods for the Analysis of Enkephalins and Endorphins-----255
R. Wayne Hendren

The Analysis of Endogenous Opioid Peptides With HPLC, Radioreceptor Assay, Radioimunoassay, and Mass Spectrometry-----304
Dominic M. Desiderio; Hisayoshi Takeshita; Hiroshi Onishi; Genevieve Fridland; Francis S. Tanzer; Claire Wakelyn; and Chhabil Dass

Reverse Phase HPLC of Peptides: Application to the Opioid Peptides-----319
Tatsuhiko Kanmera and Reginald P. Sequeira

Peptides as Drugs in the Treatment of Opiate Addiction-----337
Hemendra N. Bhargava

Progress in the Potential Use of Enkephalin Analogs-----367
Robert C. A. Frederickson

Opioid Peptides as Drug Products: FDA Regulatory Requirements-----385
Charles P. Hoiberg and Rao S. Rapaka

A Few Thoughts on the Development and Regulation of Neuropeptides-----405
John L. Gueriguian and Yuan-Yuan H. Chiu

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal